Efficacy and Safety of Rituximab in Systemic Lupus Erythematosus and Sjögren Syndrome Patients With Refractory Thrombocytopenia: A Retrospective Study of 21 Cases.
about
Treating the Underlying Pathophysiology of Primary Sjögren Syndrome: Recent Advances and Future Prospects.Characterization of patients with systemic lupus erythematosus who meet the diagnostic criteria for TAFRO syndrome.B Cell-Based Treatments in SLE: Past Experience and Current Directions.RORγt antagonist suppresses M3 muscarinic acetylcholine receptor-induced Sjögren's syndrome-like sialadenitis.
P2860
Efficacy and Safety of Rituximab in Systemic Lupus Erythematosus and Sjögren Syndrome Patients With Refractory Thrombocytopenia: A Retrospective Study of 21 Cases.
description
2015 nî lūn-bûn
@nan
2015 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Efficacy and Safety of Rituxim ...... trospective Study of 21 Cases.
@ast
Efficacy and Safety of Rituxim ...... trospective Study of 21 Cases.
@en
type
label
Efficacy and Safety of Rituxim ...... trospective Study of 21 Cases.
@ast
Efficacy and Safety of Rituxim ...... trospective Study of 21 Cases.
@en
prefLabel
Efficacy and Safety of Rituxim ...... trospective Study of 21 Cases.
@ast
Efficacy and Safety of Rituxim ...... trospective Study of 21 Cases.
@en
P2093
P2860
P1476
Efficacy and Safety of Rituxim ...... trospective Study of 21 Cases.
@en
P2093
P2860
P304
P356
10.1097/RHU.0000000000000273
P577
2015-08-01T00:00:00Z